Endometrial Cancer Market Size
Market Size in USD Bn
CAGR5.9%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 5.9% |
| Market Concentration | High |
| Major Players | GlaxoSmithKline Pharmaceuticals, Merck & Co, AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Endometrial Cancer Market Analysis
The endometrial cancer market is estimated to be valued at USD 28.10 Bn in 2025 and is expected to reach USD 41.97 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032. This robust growth can be attributed to rising incidences of endometrial cancer cases worldwide owing to changing lifestyles and growing geriatric population.